Omar Zaher

Field of research

Physiologically based pharmacokinetic (PBPK) modeling

Curriculum vitae

Since 01/2024: Doctoral student Clinical Pharmacy, Saarland University, Saarbrücken

06/2021 – 08/2021: Internship, Pharmacometrics research group, Uppsala University, Sweden

09/2020 – 08/2022: Master of pharmaceutical modeling, Uppsala University, Sweden

08/2018 – 08/2020: Senior product specialist, Sanofi Genzyme, Saudi-Arabia

06/2011 – 06/2018: Neurology product specialist, Biogen, Ägypten, Saudi-Arabia

01/2010 – 05/2011: Oncology medical representative, Hospira, Egypt

09/2005 – 06/2009: Pharmacy studies, Alexandria University, Faculty of pharmacy, Egypt

Publications

Manuscripts

Walle N, Dings C, Zaher O, Doerr AA, Peters B, Laschke MW, Lehr T, Menger MD, Schmidt PH, Meyer MR, Schaefer N. Does a carboxamide moiety alter the toxicokinetics of synthetic cannabinoids? A study after pulmonary and intravenous administration of cumyl-5F-P7AICA to pigs. Arch Toxicol. 2025. doi:10.1007/s00204-024-03906-z

Centanni M, Zaher O, Elhad D, Karlsson MO, Friberg LF. Physiologically-based pharmacokinetic models versus allometric scaling for prediction of tyrosine-kinase inhibitor exposure from adults to children. Cancer Chemother Pharmacol. 2024. doi:10.1007/s00280-024-04678-0